Journal article
Risk-based pathology reporting after endoscopic submucosal dissection for early gastrointestinal cancer: international consensus standards
Gut
07/10/2026
DOI: 10.1136/gutjnl-2025-337567
PMID: 42431725
Abstract
Endoscopic submucosal dissection (ESD) enables en bloc resection of early gastrointestinal cancers and provides specimens suitable for precise pathological risk assessment. However, reporting remains variable for key parameters that determine curative resection and the need for additional treatment, including submucosal invasion depth and breadth, margin status, lymphovascular invasion, tumour budding, differentiation and use of ancillary stains.
To develop practical international standards for pathology assessment and reporting of invasive carcinoma in ESD specimens.
An international panel of 42 experts, including 28 gastrointestinal pathologists and 14 therapeutic endoscopists from 15 countries, participated in a modified Delphi consensus process. Statements addressed measurement of invasion, margin assessment, staining, specimen handling, prognostic histological features and clinically relevant reporting.
56 recommendations reached consensus across seven domains. The panel recommends using Sm1-Sm3 subclassification only when the muscularis propria is present; otherwise, submucosal invasion depth should be reported in micrometres, rounded to the nearest 100 µm. Submucosal invasion breadth should be reported in millimetres as an adjunct metric for future validation. Margin positivity should be defined as direct tumour contact with the inked surface, supported by standardised pinning, inking, complete embedding and parallel sectioning. H&E remains the baseline stain, with selective immunohistochemistry or elastic stains for equivocal lymphovascular invasion, distorted architecture or difficult margin interpretation. Tumour budding should be reported according to International Tumour Budding Consensus Conference criteria, and differentiation, histological subtype, lymphovascular invasion, perineural invasion and margin status should be integrated into composite risk assessment.
These consensus standards provide immediately implementable, synoptic-ready pathology reporting criteria after ESD. By standardising measurement landmarks, margin terminology, ancillary stain use and reporting of adverse histological features, they aim to reduce interinstitutional variability, improve multidisciplinary decision-making and support future validation of risk models in early gastrointestinal cancer.
Details
- Title: Subtitle
- Risk-based pathology reporting after endoscopic submucosal dissection for early gastrointestinal cancer: international consensus standards
- Creators
- Kareem Khalaf - St. Michael's HospitalHuaqi Li - St. Michael's HospitalMai Iwaya - Shinshu University HospitalChristine E Orr - Queen's UniversityMark Schneider - Queen's UniversityYugo Iwaya - St. Michael's HospitalYuhong Yuan - McMaster University Medical CentreYutaka Saito - National Cancer Center Hospital EastYuto Shimamura - Austin HealthHelmut Messmann - University Hospital AugsburgJérémie Jacques - Hôpital DupuytrenCesare Hassan - Fondazione Humanitas per la RicercaAlessandro Repici - Fondazione Humanitas per la RicercaDaniel von Renteln - Centre Hospitalier de l’Université de MontréalMaría Pellisé - Consorci Institut D'Investigacions Biomediques August Pi I SunyerShaimaa Elkholy - Cairo UniversityJohn T Anderson - Gloucestershire Hospitals NHS Foundation TrustMingyan Cai - Fudan UniversityRoos E Pouw - University Medical Center UtrechtDennis Yang - AdventHealth OrlandoPhilip Wai Yan Chiu - Chinese University of Hong KongGregory Y Lauwers - Moffitt Cancer CenterMarian Priyanthi Kumarasinghe - Queen Elizabeth II Medical CentreTetsuo Ushiku - Bunkyo UniversityCatherine J Streutker - University of TorontoTao Wang - Queen's UniversityDavid Hurlbut - Queen's UniversityAndrea Grin - Queen's UniversityAndrew Bellizzi - University of IowaKyoung-Mee Kim - Sungkyunkwan UniversityAurelie Charissoux - Université de LimogesTanguy Fenouil - Université Claude Bernard Lyon 1Benoit Terris - Hôpital CochinGert de Hertogh - KU LeuvenMarnix Jansen - University College HospitalSybren L Meijer - Amsterdam University Medical CentersMichael Vieth - Bayreuth Medical CenterYukihiro Nakanishi - Moffitt Cancer CenterHiroshi Kawachi - The Cancer Institute HospitalChen Xu - Sun Yat-sen UniversityDalia Abd El-Kareem - Cairo UniversityKenichi Ohashi - Tokyo Medical and Dental UniversityIan Brown - Envoi Specialist PathologistsRichard Kirsch - Mount Sinai HospitalCharanjeet Singh - AdventHealth OrlandoKatrina Knight - Glasgow Royal InfirmaryElizabeth A Montgomery - University of MiamiMiriam Cuatrecasas - Consorci Institut D'Investigacions Biomediques August Pi I SunyerKarmele Saez de Gordoa - Hospital Clínic de BarcelonaRobert Bechara - Queen's University
- Resource Type
- Journal article
- Publication Details
- Gut
- DOI
- 10.1136/gutjnl-2025-337567
- PMID
- 42431725
- NLM abbreviation
- Gut
- ISSN
- 1468-3288
- eISSN
- 1468-3288
- Publisher
- BMJ
- Language
- English
- Electronic publication date
- 07/10/2026
- Academic Unit
- Pathology
- Record Identifier
- 9985180942102771
Metrics
2 Record Views